Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01VZL
|
||||
| Former ID |
DIB020772
|
||||
| Drug Name |
PSN632408
|
||||
| Synonyms |
PSN 632408; PSN-632,408; PSN-632408
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [540279] | ||
| Formula |
C18H24N4O4
|
||||
| InChI |
InChI=1S/C18H24N4O4/c1-18(2,3)25-17(23)22-10-6-14(7-11-22)24-12-15-20-16(21-26-15)13-4-8-19-9-5-13/h4-5,8-9,14H,6-7,10-12H2,1-3H3
|
||||
| InChIKey |
LHZWKWCEAXQUMX-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Glucose-dependent insulinotropic receptor | Target Info | Agonist | [528067] | |
| KEGG Pathway | cAMP signaling pathway | ||||
| Insulin secretion | |||||
| WikiPathways | Incretin Synthesis, Secretion, and Inactivation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.